ArticleVeterinary research communications2025
Molecular and phylogenetic characterization of Staphylococcus aureus isolated from primary pyoderma in a goat from tropical India: an emerging zoonotic threat.
Article in Veterinary research communications, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Staphylococcus aureus is a globally prevalent zoonotic pathogen frequently associated with pyoderma in humans; however, molecular data on primary staphylococcal pyoderma in Indian goats are meagre. This report presents the first molecular identification and phylogenetic analysis of S. aureus from a goat with primary pyoderma, along with clinical management. A four-month-old Malabari crossbred goat kid was presented to the Teaching Veterinary Clinical Complex, Mannuthy, with pustules and scab-like lesions on perianal and abdominal skin. Dermatological evaluation indicated primary pyoderma, and impression smears revealed Gram-positive cocci and neutrophils. The isolate was catalase positive and exhibited sensitivity to tetracycline, gentamicin, amoxicillin-sulbactam, ceftriaxone-tazobactam, and streptomycin, but showed resistance to multiple antibiotics. The isolate was identified as S. aureus by 16S rRNA gene sequencing. BLAST analysis revealed 99.48% sequence identity with S. aureus strains isolated from human cases of sepsis and pyoderma in Uzbekistan, India, and the USA, as well as with a complete genome sequence of a human blood isolate from Brazil. Phylogenetic analysis further demonstrated clustering with human isolates reported from multiple continents. A combination therapy of ceftriaxone-tazobactam and gentamicin for seven days based on culture and sensitivity test led to complete recovery. The genetic proximity to human pathogenic strains across diverse regions highlighted the broad host range of the bacterium. The findings of present study underscore the need for molecular surveillance, antimicrobial stewardship, and integrated One Health strategies to mitigate emerging zoonotic threats, particularly in regions with frequent human-livestock contact.
Indexed as
Identifiers
41345815What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.